"10.1371_journal.pone.0009606","plos one","2010-03-09T00:00:00Z","Rønnaug Solberg; David Enot; Hans-Peter Deigner; Therese Koal; Sabine Scholl-Bürgi; Ola D Saugstad; Matthias Keller","Department of Pediatric Research, Oslo University Hospital, Rikshospitalet, University of Oslo, Norway; Department for Surgical Research, Oslo University Hospital, Rikshospitalet, University of Oslo, Norway; BIOCRATES Life Sciences AG, Innsbruck, Austria; Innsbruck Medical University, Department of Pediatrics IV, Division of Neuropediatrics and Inherited Metabolic Disorders, Innsbruck, Austria; Department of Pediatrics I, Neonatology, University Essen, Essen, Germany","Conceived and designed the experiments: RS ODS MK. Performed the experiments: RS DE HPD TK. Analyzed the data: RS DE HPD TK SSB MK. Contributed reagents/materials/analysis tools: RS DE HPD TK SSB ODS MK. Wrote the paper: RS DE SSB ODS MK.","The results of this study (biomarkers of hypoxia severity) are submitted to the European Patent Agency for IP protection by the authors under the guidance of BIOCRATES Life Sciences AG. David Enot, Hans-Peter Deigner, Therese Koal and Matthias Keller were (Keller) or still are employers of BIOCRATES Life Sciences AG. Financial competing interests are: Paid employment or consultancy and Patent applications (pending). The authors confirm that this does not alter their adherence to all the PLoS ONE polices on sharing data and materials, as detailed online in PLoS ONE guide for authors. The first author, Rønnaug Solberg, used her non commercial funding (from South-Eastern Norway Regional Health Authority and Norwegian SIDS and Stillbirth Society) to pay for analyses done by Biocrates. The patent number is: EP09159425.9 Method of diagnosing asphyxia 05.05.2009.","2010","03","Rønnaug Solberg","RS",7,TRUE,3,4,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
